On The Pen With Dave Knapp

By: Dave Knapp Man On The Mounjaro Bleav
  • Summary

  • Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
    © 2025 On The Pen With Dave Knapp
    Show More Show Less
Episodes
  • 503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25
    Feb 18 2025

    📚 Book Relaunch: The book “Decoding GLP-1” is back on Amazon, now priced at $10, thanks to community advocacy.
    ⏳ Compounding Update: The FDA has delayed enforcement on 503A pharmacies until a court ruling expected by February 25.
    🔬 Fat Cell Research: New findings suggest fat cells may help tailor obesity treatments based on individual profiles.
    💊 PBM Concerns: Advocacy for Pharmacy Benefit Manager reform highlights their impact on drug prices and patient access.
    📈 Investor Insights: Amalin shows promise in obesity treatment, with new research indicating its effects on appetite and food choices.
    🏥 Upcoming Medications: Kagema is anticipated to hit the market in early 2026, alongside new developments from various companies.
    🎉 Community Engagement: The podcast encourages listeners to subscribe and support ongoing efforts in obesity medicine discussions

    Show More Show Less
    23 mins
  • Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101
    Feb 14 2025

    On the 101st episode of On The Pen Live, Dave discusses this week's news in GLP-1, we get weight loss maintenance tips from Korrie, and a Reddit recap from @FitFlavorFun ! For the interview portion, Dave welcomes Charles aka @RoundMoundofZepbound to discuss his health story as well as dealing with a cancer diagnosis after Zepbound weight loss.

    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
    📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
    📖Paperback: https://amzn.to/4gAXrz4

    💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%.

    SOCIALS:
    📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
    🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
    👾: https://discord.gg/ZHeUh7WV
    📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
    ❌: https://x.com/manonthepen?s=21
    💻: https://www.onthepen.com

    #zepbound #mounjaro #onthepen

    Show More Show Less
    1 hr and 30 mins
  • Lilly Announces Next Gen Tirzepatide
    Feb 11 2025

    Breaking Compound Tirzepatide News
    Lilly announces next generation of GLP-1 / GIP med
    Trump advocates for cheaper "Fat Shot"
    HIMS faces industry scrutiny

    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
    📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
    📖Paperback: https://amzn.to/4gAXrz4

    💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%.

    SOCIALS:
    📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
    🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
    👾: https://discord.gg/ZHeUh7WV
    📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
    ❌: https://x.com/manonthepen?s=21
    💻: https://www.onthepen.com

    #zepbound #mounjaro #onthepen

    Show More Show Less
    31 mins

What listeners say about On The Pen With Dave Knapp

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.